Posts filed under: Pharmaceuticals

OncoSec and Inovio Pharmaceuticals have announced they are testing potential COVID-19 vaccines and pursuing first-in-human Phase 1 clinical trials. As of April 9, the FDA has not approved any preventative or therapeutic coronavirus vaccines for use against the SARS-CoV-2 coronavirus...
Continue Reading →
Coronavirus and Ibuprofen: Is it safe to take? Medical professionals no longer recommend using ibuprofen to manage coronavirus symptoms. The health minister of France, Olivier Véran has warned citizens to avoid taking ibuprofen to treat symptoms of the coronavirus after...
Continue Reading →
Register to receive a free Global Immunology Drugs Market Report Suite report synopsis and brochure The Japan Ministry of Health, Labour and Welfare has recently approved AbbVie’s Skyrizi for treatment of three categories of psoriasis and psoriatic arthritis. This international approval is...
Continue Reading →
Register to receive a free Global Immunology Drugs Market Report Suite report synopsis and brochure The United States Food and Drug Administration (FDA) has recently issued an alert regarding Xeljans (tofacitinib) in treating rheumatoid arthritis patients. The public alert stated that a...
Continue Reading →
Register to receive a free Europe Market Report Suite for Immunology Drugs report synopsis and brochure Sandoz, a biosimilar developer, recently announced the launch of their Hyrimoz product in Spain. The biosimilar references and is approved for all adalimumab (Humira)...
Continue Reading →
Register to receive a free Global Immunology Drugs Market Report Suite report synopsis and brochure The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking...
Continue Reading →
Register to receive a free Global Immunology Drugs Market report synopsis and brochure By Kamran Zamanian and Jacqueline Ding, iData Research Inc. The United States is still an emerging market for biosimilars due to unclear regulatory requirements and unresolved lawsuits pertaining...
Continue Reading →
Register to receive a free Global Immunology Drugs Market Report Suite 2018-2024 report synopsis and brochure Eli Lilly and Company announced Taltz® (ixekizumab) met the primary and all major secondary endpoints in the Phase 3b/4 SPIRIT-H2H study, which evaluated the efficacy and safety of...
Continue Reading →
Register to receive a free Global Immunology Drugs Market Report Suite 2018-2024 report synopsis and brochure Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, announced a definitive agreement by which it will be acquired by...
Continue Reading →
Register to receive a free Global Immunology Drugs Market Report Suite 2018-2024 report synopsis and brochure Takeda Pharmaceutical Company Limited (“Takeda”) announced the results of the shareholder votes at its Extraordinary General Meeting of Shareholders (“EGM”) regarding the recommended acquisition of Shire...
Continue Reading →
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link